Page 3 - Gene Kinney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau

Prothena to receive $55 million from Bristol Myers Squibb for exclusive worldwide license to PRX005, building on exclusive U.S. license which was optioned in June 2021Bristol Myers Squibb will be responsible for development, manufacturing, and commercialization going forward DUBLIN (BUSINESS WIRE) $PRTA #prothena-.

Michael bachnerRichard hargreavesBristol myers squibbProthena corporationCorporate communicationsCompany on twitter prothenacorpExchange commissionMyers squibbGene kinneyChief executive officerSenior vice presidentNeuroscience thematic researchQuarterly reportInvestor contactSenior director

BMS obtains global rights to Prothena s Alzheimer s drug in deal worth $2 2bn

BMS obtains global rights to Prothena s Alzheimer s drug in deal worth $2 2bn
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Richard hargreavesBristol myers squibbDrug administrationNeuroscience thematic research centerAlzheimer societyBristol myersMyers squibbGene kinney

Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody

Prothena to receive $55 million from Bristol Myers Squibb for exclusive worldwide license to PRX005, building on exclusive U.S. license which was optioned in June 2021 Bristol Myers Squibb will be responsible for development, manufacturing, and commercialization going forward

Richard hargreavesBristol myers squibbCompany on twitter prothenacorpProthena corporationExchange commissionGene kinneyChief executive officerSenior vice presidentNeuroscience thematic researchQuarterly report

Prothena Corporation plc: Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody

Prothena Corporation plc: Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Michael bachnerRichard hargreavesProthena corporationCompany on twitter prothenacorpCorporate communicationsExchange commissionBristol myers squibbMyers squibbGene kinneyChief executive officerSenior vice presidentNeuroscience thematic researchQuarterly reportInvestor contactSenior directorIhre watchlist

Prothena Corp (PRTA) Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody

Prothena Corp (PRTA) Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Richard hargreavesProthena corporationBristol myers squibbGene kinneyChief executive officerSenior vice presidentNeuroscience thematic research